Ophthalmic Immunosuppressants
Key Points
- Cyclosporine is the primary topical ocular immunosuppressant used as a steroid-sparing anti-inflammatory strategy.
- Typical indication is dry eye syndrome due to keratoconjunctivitis sicca.
- Most adverse effects are local (burning, blurry vision, redness, ocular discomfort), but hypersensitivity can occur.
- Contact lenses should be removed before dosing and reinserted about 15 minutes later.
- Concurrent topical corticosteroids can increase infection risk.
Class Overview
Topical cyclosporine acts as a partial ocular immunomodulator and supports tear production in inflammation-suppressed tear pathways. It is used to reduce recurrent immune-mediated ocular-surface inflammation and can support longer-term disease control.
Prototype Dosing and Use
| Drug | Typical Adult Ophthalmic Dosing | Indication |
|---|---|---|
| Cyclosporine 0.05% | 1 drop in each eye twice daily, about 12 hours apart | Keratoconjunctivitis sicca / dry-eye inflammation |
Artificial tears may be used concurrently when spaced from cyclosporine administration (commonly about 15 minutes apart).
Adverse Effects and Contraindications
- Ocular burning/stinging, blurry vision, conjunctival hyperemia, eye pain, pruritus, epiphora
- Hypersensitivity reactions including periorbital/facial swelling, tongue/pharyngeal edema, and dyspnea
- Rare anaphylactic-pattern reactions
- Contraindication: hypersensitivity to active or inactive ingredients
Nursing Assessment and Interventions
- Monitor for hypersensitivity signs (facial swelling, tongue inflammation, dyspnea).
- Validate no-touch drop-instillation technique with return-demonstration.
- If the client is immunocompromised, reinforce early reporting of infection symptoms.
- Review concurrent steroid use and infection-risk context before regimen continuation.
Client Education
- Invert single-dose vial until the emulsion appears uniform before instillation.
- Use immediately after opening and discard leftover solution.
- Do not allow vial tip to touch eye or other surfaces.
- Remove contact lenses before administration and wait about 15 minutes before reinsertion.
- Separate other ocular drops/ointments by at least about 15 minutes.
Related Concepts
- ophthalmic-corticosteroids - Concurrent use can increase infection risk.
- ophthalmic-medication-administration - Instillation and contamination-prevention technique.
- immunosuppressants - Broader immune-modulation and infection-risk framework.
- eye-assessment-visual-acuity-and-common-abnormalities - Ocular symptom reassessment during therapy.